Chemed (CHE) news

Chemed shares quickly extend drop to 4%

Chemed (CHE) shares continued to decline on August 27, 2026, extending their drop to a 4% loss, with the stock trading at $529.39 as of market close. The decline follows a broader sell-off after the company reported earnings that fell short of expectations in its most recent quarterly report. For…

Chemed boosts quarterly dividend to 70c from 60c

Chemed Corporation (NYSE: CHE) has announced an increase in its quarterly dividend, raising the payout to $0.70 per share from $0.60 per share, representing a 16.7% increase. The new dividend will be paid on October 15, 2026, to shareholders of record as of September 20, 2026, with an ex-dividend…

Chemed Corporation: Oppenheimer raises target price to $590 from $500

Chemed Corp - Vitas FY2026 guidance: ADC growth 5.75%-6.25%, revenue growth ex-Medicare cap 8.25%-9.25%

Chemed sees FY adj EPS $25.00 to $25.75, saw $24 to $24.75

Chemed Corporation (NYSE: CHE) has raised its full-year 2026 adjusted earnings per share (EPS) guidance to a range of $25.00 to $25.75, up from the previous range of $24 to $24.75. This update reflects improved performance across its two primary segments, VITAS Healthcare Corporation and…